As versatile therapeutic agents, GLP-1RAs demonstrated their benefits across a range of pain syndromes, including inflammatory nociception, visceral hypersensitivity, neuropathic pain, diabetic peripheral neuropathy (DPN), cancer pain and headaches (Fig
4,6,7 Large observational analyses have reported lower risks for several neuropsychiatric outcomes, including substance use and psychotic disorders
Retatrutide is more accurately described as an investigational triple-receptor medication targeting GLP-1, GIP, and glucagon pathways
Support patients in navigating their dietary preferences and maintaining adequate intake
In brief, chemical standard libraries of 149 metabolites in seven pooled libraries were prepared and serially diluted in high-performance liquid chromatography (HPLC)-grade water from in a dilution series from 5 mM to 1 M to generate external standard pools, which are used for calibration of isotopically labelled internal standards and to quantify concentrations of metabolites for which internal standards were not available